Stock Trim Losses -...
Health Care: Drugs
Santarus Inc. (SNTS: NASDAQ)
$22.93 0.65 | 2.92%
05/23/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:43.73
Price Earnings Comparisons:
| SNTS | Sector Avg. | S&P 500 |
|---|---|---|
| 43.73 | 43.70 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 70.49 | 284.14 | 679.72 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 83.50 | 0.26 | 0.08 |
| Net Income | 297.40 | -0.42 | -0.17 |
| EPS | 285.70 | -0.45 | -0.18 |
Earnings for SNTS:
| EBITDA | 26.30M |
| REVENUE | 217.96M |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $0.17 | $0.20 | $0.88 | $1.29 |
| Number of Analysts | 4 | 4 | 4 | 4 |
| High Estimate | $0.24 | $0.24 | $0.97 | $1.35 |
| Low Estimate | $0.13 | $0.13 | $0.82 | $1.22 |
| Prior Year | $0.05 | $0.13 | $0.27 | $0.88 |
| Growth Rate (Year over Year) | 235.00% | 55.77% | 225.00% | 47.29% |
Portfolios with SNTS
- Portfolio NameUser Type
- UserWatch
- ContributorStocks Under-$10 Setting Up...
- ContributorDrugs Facing FDA Approval i...
- ContributorBreakout Stocks Of The Week...
- UserRogers BioMed
- ContributorStocks At New 52-Week Highs...
- UserJust Learning ao926
- UserJust Learning
- ContributorDollar Store
- Userbetterlatethannever
Latest SNTS Headlines from TheStreet
- Dow Closes at Record High 03.05.13 | 04:03 pm
- Cramer's 'Mad Money' Recap: The Bullish Facts 01.17.13 | 08:01 pm
- 5 Stocks Insiders are Buying This Week 12.26.12 | 12:12 pm
- Top Insider Trades: LMCA, ST, SNTS, BEAV 12.20.12 | 01:12 pm
- Stocks Under $5: Discount Drug Name
11.29.12 | 06:11 am - 5 Under-$10 Stocks Set to Trade Higher in November 11.08.12 | 01:11 pm
- Santarus Inc. Stock Upgraded (SNTS) 08.27.12 | 05:08 am
- Santarus' CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.07.12 | 09:08 pm
- Santarus Reaches New 52-Week High (SNTS) 06.12.12 | 04:06 pm
- Santarus Stock Falls On Unusually High Volume (SNTS) 05.30.12 | 04:05 pm
Press Releases for SNTS
- Santarus Announces Publication In Gut Of Results From UCERIS (budesonide) European Pivotal Clinical Study - Business Wire 03.18.13 | 07:03 am
- Santarus And VeroScience Announce Publication Of AACE Expert Panel Recommendations For CYCLOSET® (bromocriptine Mesylate) For The Management Of Type 2 Diabetes - Business Wire 03.06.13 | 07:03 am
- Santarus Reports Fourth Quarter And Full Year 2012 Financial Results - Business Wire 03.04.13 | 04:03 pm
- Santarus To Present At March Investment Conferences - Business Wire 02.27.13 | 07:02 am
- Santarus To Hold Fourth Quarter And Full Year 2012 Financial Results Conference Call On March 4 - Business Wire 02.19.13 | 07:02 am
- Santarus Announces Commercial Launch Of UCERIS (budesonide) Extended Release Tablets - Business Wire 02.14.13 | 07:02 am
- Santarus To Present At Leerink Swann Global Healthcare Conference - Business Wire 02.06.13 | 07:02 am
- Santarus And VeroScience Announce Publication Of Positive Data From Pivotal CYCLOSET® (bromocriptine Mesylate) Efficacy Study - Business Wire 01.23.13 | 07:01 am
- Santarus Receives FDA Approval Of UCERIS (Budesonide) For The Induction Of Remission In Patients With Active, Mild To Moderate Ulcerative Colitis - Business Wire 01.14.13 | 07:01 pm
- Santarus And VeroScience Announce Publication Of New Analysis Of CYCLOSET (bromocriptine Mesylate) Cardiovascular Data In The Journal Of The American Heart Association - Business Wire 11.13.12 | 07:11 am
Partner Headlines for SNTS
- FDA Panel Kills Sefelsa, Creates Buying Opportunity In Depomed Stock - Seeking Alpha 03.05.13 | 09:03 am
- Roth Capital's Henry Sees Upcoming FDA Panel For Depomed's Sefelsa As A Coin Flip - Seeking Alpha 03.01.13 | 05:03 pm
- Serada Approval Presents Big Upside To Depomed - Seeking Alpha 01.30.13 | 09:01 am
- Three Compelling Biopharma Stocks For 2013 - Seeking Alpha 12.26.12 | 09:12 am
- 5 BioPharmas To Watch For Wednesday, September 5 - Seeking Alpha 09.05.12 | 09:09 am
- Santarus - Momentum - Zacks 07.18.12 | 01:07 am
- Verizon and 2 Stocks BREAKING 52-Week Highs - Wall St. Cheat Sheet 06.13.12 | 12:06 pm
- Most Volatile Stocks on Earnings Report Days - Seeking Alpha 01.07.11 | 07:01 pm
- UPDATE 1-Santarus files for approval of anti-swelling drug - Reuters 12.28.10 | 09:12 am
- Santarus' Q3 Loss: The Rough Path to Recovery - Seeking Alpha 11.09.10 | 09:11 am
